Neuroblastoma: open trials in Denmark

• NCT07549321

  A Safety and Efficacy Study of hu14 in High-Risk Neuroblastoma Patients

  Trial Treatment · Phase 2/3 · Renaissance Pharma Ltd.

  Rigshospitalet, Copenhagen

  Registry updated 2026-11-03

• NCT06395103

  Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

  Trial Treatment · Phase 1/2 · Merck Sharp & Dohme LLC

  Rigshospitalet, Copenhagen Oe

  Registry updated 2026-10-30

• 2023-504880-18-00

  A phase 1B of crizotinib either in combination or as single agent in pediatric patients with ALK, ROS1 or MET positive malignancies

  Trial Treatment · Phase 1/2 · Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)

  Rigshospitalet, Copenhagen Oe

  Registry updated 2026-05-07

• NCT07334301

  A Multi-Arm, Platform Trial For Relapsed Neuroblastoma

  Trial Treatment · Phase 1/2 · University of Birmingham

  Rigshospitalet, Copenhagen Oe

  Registry updated 2026-01-12

• NCT04221035

  High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN)

  Trial Treatment · Phase 3 · Gustave Roussy, Cancer Campus, Grand Paris

  Aarhus Universitetshospital, Århus · Rigshospitalet, Copenhagen Oe · Odense University Hospital, Odense C

  Registry updated 2025-06-26

• NCT04903899

  177Lutetium-DOTATATE in Children With Primary Refractory or Relapsed High-risk Neuroblastoma

  Trial Treatment · Phase 2 · Jakob Stenman

  Rigshospitalet, Copenhagen Oe

  Registry updated 2025-02-11

• NCT05826158

  18F-mFBG LAFOV PET/CT Compared to 123I-mIBG Scintigraphy SPECT/CT for Evaluation of Children With Neuroblastoma

  Trial Treatment · Copenhagen University Hospital, Rigshospitalet

  Rigshospitalet (Copenhagen University Hospital), Copenhagen

  Registry updated 2024-11-15

All Neuroblastoma trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error